Fig. 5
From: Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
Annual Rate of Serious Medical Outcomes per One Million US Population Associated with Gabapentin and Pregabalin Exposures Reported to the National Poison Data System by Age Group, 2012–2022